Homatropine Ophthalmic Side Effects
Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.
Applies to homatropine ophthalmic: ophthalmic solution.
Side effects include:
Elevated IOP, transient stinging, burning. With prolonged administration, local irritation (characterized by follicular conjunctivitis, vascular congestion, edema, exudate, and eczematoid dermatitis ), thirst, dry mouth, increased light sensitivity of eyes.
For healthcare professionals
Applies to homatropine ophthalmic: compounding powder, ophthalmic solution.
General adverse events
The most frequently reported side effects were transient stinging/burning upon instillation and increased sensitivity to light.[Ref]
Ocular
- Common (1% to 10%): Transient burning, transient stinging, increased sensitivity to light
- Uncommon (0.1% to 1%): Eye irritation
- Rare (0.01% to 0.1%): Local irritation, vascular congestion, edema, exudates, eczematoid dermatitis, follicular conjunctivitis
- Postmarketing reports: Conjunctivitis, photophobia, mydriasis prolonged, eye pain, eye edema, eye discharge, eye irritation, ocular hyperemia[Ref]
Gastrointestinal
- Rare (0.01% to 0.1%): Thirst, dryness of mouth
- Frequency not reported: Abdominal distention infants, gastrointestinal motility diminished, salivary secretion decreased, sweat gland secretion decreased[Ref]
Nervous system
- Frequency not reported: Ataxia, incoherent speech, hyperactivity, seizure, unusual drowsiness
- Postmarketing reports: Somnolence[Ref]
Psychiatric
- Frequency not reported: Restlessness, hallucination, disorientation, failure to recognize people
- Postmarketing reports: Confusion[Ref]
Genitourinary
- Frequency not reported: Urinary retention[Ref]
Respiratory
- Frequency not reported: Secretion decreased in pharynx/bronchi/nasal passages, rapidly progressive respiratory depression[Ref]
Other
- Frequency not reported: Hyperpyrexia[Ref]
Cardiovascular
- Frequency not reported: Tachycardia, vasodilation, hypotension
- Postmarketing reports: Heart rate increased[Ref]
Dermatologic
See also:
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Triamcinolone ophthalmic
Triamcinolone ophthalmic is used for macular edema, temporal arteritis, uveitis, vitrectomy
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Maxitrol
Maxitrol is used for blepharitis, conjunctivitis, bacterial, keratitis, keratoconjunctivitis, uveitis
Tropicacyl
Tropicacyl is used for pupillary dilation, refraction, assessment
Mydriacyl
Mydriacyl is used for pupillary dilation, refraction, assessment
Cyclogyl
Cyclogyl is used for pupillary dilation, refraction, assessment, uveitis
Cyclopentolate ophthalmic
Cyclopentolate ophthalmic is used for pupillary dilation, refraction, assessment, uveitis
Tropicamide ophthalmic
Tropicamide ophthalmic is used for organophosphate poisoning, pupillary dilation, refraction, assessment
References
1. Cerner Multum, Inc. "Australian Product Information."
2. (2017) "Product Information. Homatropine Hydrobromide (homatropine ophthalmic)." OCuSOFT
More about homatropine ophthalmic
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: mydriatics
- Breastfeeding
- En español
Patient resources
Other brands
Homatropaire, Isopto Homatropine
Professional resources
Related treatment guides
Further information
Homatropine ophthalmic side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.